Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patients


Kebapcilar L., Bilgir O., Taner C. E., Kebapcilar A. G., Kozaci D. L., Alacacioglu A., ...More

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.281, no.3, pp.539-543, 2010 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 281 Issue: 3
  • Publication Date: 2010
  • Doi Number: 10.1007/s00404-009-1189-7
  • Journal Name: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.539-543
  • Keywords: sCD40L, Ethinylestradiol, Cyproterone acetate, Spironolactone, PCOS, POLYCYSTIC-OVARY-SYNDROME, SYSTEMIC-LUPUS-ERYTHEMATOSUS, CARDIOVASCULAR RISK, ENDOTHELIAL-CELLS, CD40 LIGAND, T-CELLS, EXPRESSION, ESTROGEN, FIBRINOLYSIS, ACTIVATION
  • Dokuz Eylül University Affiliated: No

Abstract

The present study was designed to determine the effect of oral contraceptives (OCP) and OCP plus spironolactone (Sp) on plasma soluble CD40L levels in polycystic ovary syndrome (PCOS) patients.